US Patent 7138418 Pentafluorobenzenesulfonamides and analogs
Patent 7138418 was granted and assigned to Amgen on November, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Bei Shan0
David L. Clark0
John Flygare0
Julio C. Medina0
Terry J. Rosen0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+455 characters)
Article
Patent abstract
The invention provides methods and compositions relating to novel pentafluorophenylsulfonamide derivatives and analogs and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents. The compositions include compounds of the general formula I:
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07138418 Pentafluorobenzenesulfonamides and analogs US Patent 7138418 Pentafluorobenzenesulfonamides and analogs
Infobox
Patent Number
07138418
Patent Number
7138418
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07138418 Pentafluorobenzenesulfonamides and analogs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07138418
Date of patent
November 21, 2006
Patent application number
09972743
Date Filed
October 5, 2001
Patent primary examiner
Find more entities like US Patent 7138418 Pentafluorobenzenesulfonamides and analogs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
